References
-
1
Goodnough L T, Despotis G J, Hogue C W, Ferguson T BJ.
On the need for improved transfusion indicators in cardiac surgery.
Ann Thorac Surg.
1995;
60
473-480
-
2
Surgenor D M, Churchill W H, Wallace E L. et al .
The specific hospital significantly affects red cell and component transfusion practice in coronary artery bypass graft surgery: a study of five hospitals.
Transfusion.
1998;
38
122-134
-
3
Stover E P, Siegel L C, Parks R. et al .
Variability in transfusion practice for coronary artery bypass surgery persists despite national consensus guidelines.
Anesthesiology.
1998;
88
327-333
-
4 Sirchia G, Giovanetti A M, McClelland D BL, Fracchia G N. Safe and good use of blood in surgery (SANGUIS). Use of blood products and artificial colloids in 43 European hospitals. European Commission, European Community, Brussels 1994
-
5
Baele P, Beguin C, Waterloos H. et al .
The Belgium BIOMED Study about transfusion for surgery.
Acta Anaesth Belg.
1998;
49
243-303
-
6
Salem-Schatz S R, Aworn J, Soumerai S B.
Influence of clinical knowledge, organizational context and practice style on transfusion decision making: implications for practice change strategies.
J Am Med Assoc.
1990;
264
476-483
-
7 Van der Linden P, De Hert S, Daper A, Trenchant A, Jacobs D, De Boelpaepe C, Kimbimbi P, Defrance P, Simoens G. A Standardised Multidisciplinary Approach Reduces the Use of Allogeneic Blood Products in Patients Undergoing Cardiac Surgery. Can J Anesth (in press).
Prof. Dr. Philippe Van der Linden
Service d' Anesthésie Cardiaque C.H.U. de Charleroi,
Espace Santé
Site de Jumet
73 rue de Gosselies
6040 Jumet, Belgien
